Time to treatment intensification with GLP-1 receptor agonists for patients with type 2 diabetes in the UK: medical record review study

被引：0
|
作者：
Norrbacka, K. [1 ]
Stein, D. [2 ]
Matza, L. S. [3 ]
Jordan, J. B. [3 ]
Garcia-Perez, L. -E. [4 ]
Hassan, S. W. [4 ]
Boye, K. S. [4 ]
机构：
[1] Eli Lilly Finland, Helsinki, Finland
[2] Evidera, London, England
[3] Evidera, Bethesda, MD USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
746
引用
收藏
页码：S363 / S364
页数：2
相关论文
共 50 条
  • [31] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [32] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Kristina S. Boye
    Dara Stein
    Louis S. Matza
    Jessica Jordan
    Ren Yu
    Kirsi Norrbacka
    Syed Wasi Hassan
    Luis-Emilio García-Pérez
    Drugs in R&D, 2019, 19 : 213 - 225
  • [33] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Boye, Kristina S.
    Stein, Dara
    Matza, Louis S.
    Jordan, Jessica
    Yu, Ren
    Norrbacka, Kirsi
    Hassan, Syed Wasi
    Garcia-Perez, Luis-Emilio
    DRUGS IN R&D, 2019, 19 (02) : 213 - 225
  • [34] Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
    Nauck, Michael A.
    Meier, Juris J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R211 - R234
  • [35] GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes A Direct Comparison of Glycemic Control
    Seufert, J.
    DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (03) : 141 - 147
  • [36] GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
    Ahrén, B
    Schmitz, O
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 867 - 876
  • [37] GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date
    Brunton, Stephen A.
    Wysham, Carol H.
    POSTGRADUATE MEDICINE, 2020, 132 : 3 - 14
  • [38] GLP-1 Agonists: Improving the Future of Patients With Type 2 Diabetes
    Shubrook, Jay H.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (02): : ESII - ES1
  • [39] GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
    Marx, Nikolaus
    Husain, Mansoor
    Lehrke, Michael
    Verma, Subodh
    Sattar, Naveed
    CIRCULATION, 2022, 146 (24) : 1882 - 1894
  • [40] Diagnosed Nutritional Deficiencies Among Patients With Type 2 Diabetes on GLP-1 Receptor Agonists
    Butsch, W. Scott
    Kerr, Kirk
    Chang, Andrew
    Kim, Jeeyun
    Sulo, Suela
    Williams, Dominique
    Hegazi, Refaat
    Heymsfield, Steven
    OBESITY, 2024, 32 : 189 - 190
12345